GlassScriptPhysician profile
Robert F Armstrong
NPI 1518945617
$52,664.06
in general payments reported to CMS, 2019-2025
93 companies · $2,978 in 2025
The $2,978 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $12K · 2021: $4,117 · 2022: $6,516 · 2023: $3,216 · 2024: $3,195 · 2025: $2,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,249 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,248.80 |
| Education | $140.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $21,163.39 | 2019-2025 | |
| Livanova USA, INC. | $5,280.81 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sk Life Science, INC. | $4,743.37 | 2020-2025 | |
| Aquestive Therapeutics, INC. | $4,212.82 | 2019-2021 | |
| Abbvie INC. | $1,313.06 | 2021-2025 | Botox, Ubrelvy, Duopa |
| Ucb, INC. | $1,225.97 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Biogen, INC. | $969.03 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Mdd US Operations, LLC | $914.87 | 2020-2025 | Gocovri, Apokyn, Xadago |
| Novartis Pharmaceuticals Corporation | $778.05 | 2019-2025 | Kesimpta |
| Sunovion Pharmaceuticals INC. | $715.29 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $598.79 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $520.92 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $503.99 | 2019-2025 | Ultomiris, Soliris |
| Amgen INC. | $456.55 | 2019-2025 | Uplizna, Aimovig |
| Tg Therapeutics, INC. | $431.68 | 2023-2025 |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $382.32 | 2019-2025 | Emgality, Amyvid, Reyvow |
| Celgene Corporation | $375.10 | 2021-2025 | Zeposia |
| Neurocrine Biosciences, INC. | $372.32 | 2019-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $366.95 | 2019-2025 | Mavenclad |
| Acadia Pharmaceuticals INC | $335.89 | 2019-2025 | Nuplazid, Daybue |
| Allergan, INC. | $329.11 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $315.43 | 2019-2022 | |
| Genzyme Corporation | $314.55 | 2019-2025 | |
| Averitas Pharma INC. | $310.86 | 2023-2025 | Qutenza |
| Greenwich Biosciences, INC. | $301.87 | 2019-2021 | |
| Pfizer INC. | $296.61 | 2019-2025 | |
| Neurelis, INC. | $289.71 | 2020-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $257.72 | 2019-2025 | Rytary, Crexont, Brekiya |
| Csl Behring | $253.68 | 2019-2025 | Hizentra |
| Lundbeck LLC | $244.85 | 2020-2025 | Vyepti |
| Genentech USA, INC. | $242.68 | 2019-2025 | Enspryng, Ocrevus Zunovo, Ocrevus |
| Acorda Therapeutics, INC | $199.78 | 2019-2023 | Ampyra, Inbrija |
| Catalyst Pharmaceuticals, INC. | $192.73 | 2021-2025 | Fycompa |
| Argenx US, INC. | $159.92 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| E.R. Squibb & Sons, L.L.C. | $138.20 | 2020-2024 | Zeposia |
| Mallinckrodt Hospital Products INC. | $137.97 | 2021-2025 | Acthar |
| Janssen Pharmaceuticals, INC | $134.24 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $130.12 | 2023-2024 | Aptiom |
| Merz Pharmaceuticals, LLC | $127.52 | 2021-2025 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $121.12 | 2021-2025 | Dysport |
| Takeda Pharmaceuticals U.S.A., INC. | $112.65 | 2019-2025 | Hyqvia |
| Mallinckrodt Enterprises LLC | $110.22 | 2019 | |
| Horizon Therapeutics Plc | $104.56 | 2022-2023 | Uplizna |
| Avanir Pharmaceuticals, INC. | $99.40 | 2020-2022 | |
| Abbott Laboratories | $96.39 | 2021-2025 | Infinity |
| Tanabe Pharma America, INC. | $94.09 | 2021-2025 | Radicava |
| Upsher-Smith Laboratories LLC | $90.05 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $89.44 | 2022-2024 | Ztlido |
| Astrazeneca Pharmaceuticals LP | $87.20 | 2022-2025 | Wainua |
| Ultragenyx Pharmaceutical INC. | $76.09 | 2024-2025 | Dojolvi |
| Kyowa Kirin, INC. | $74.99 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $74.88 | 2022-2024 | Amvuttra |
| Axsome Therapeutics, INC. | $72.72 | 2023-2025 | Sunosi, Symbravo |
| Xeris Pharmaceuticals, INC. | $69.81 | 2021-2024 | Keveyis |
| Cycle Pharmaceuticals INC | $67.48 | 2025 | Tascenso Odt, Ormalvi, Bafiertam |
| Ani Pharmaceuticals, INC. | $62.01 | 2022-2024 | Purified Cortrophin Gel |
| Grifols USA, LLC | $60.34 | 2019-2022 | |
| Insightec,INC | $57.42 | 2023 | Exablate |
| Biohaven Pharmaceutical Holding Company LTD. | $56.34 | 2022 | |
| Medtronic, INC. | $56.14 | 2024-2025 | Intellis Adaptivestim, Percept PC Brainsense |
| Biohaven Pharmaceuticals, INC. | $53.51 | 2021 | |
| Grt US Holding, INC. | $51.65 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $50.79 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $49.43 | 2020-2021 | |
| Banner Life Sciences, LLC | $47.00 | 2022 | |
| Cala Health, INC. | $42.58 | 2022-2023 | Cala Trio |
| Octapharma USA, INC. | $41.76 | 2022-2023 | Panzyga |
| Piramal Critical Care | $41.51 | 2019 | |
| Neuropace, INC. | $39.39 | 2022-2023 | |
| Vanda Pharmaceuticals INC. | $36.00 | 2025 | Ponvory |
| Adamas Pharmaceuticals, INC. | $33.70 | 2019-2021 | |
| C2n Diagnostics, LLC | $27.78 | 2025 | Precivityad2 |
| Janssen Biotech, INC. | $26.13 | 2025 | |
| Assertio Therapeutics, INC. | $26.10 | 2019-2020 | |
| Ge Healthcare | $23.19 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $23.07 | 2025 | Lumryz |
| Mylan Specialty L.P. | $22.63 | 2024 | Glatiramer Acetate |
| Aprecia Pharmaceuticals, LLC | $22.13 | 2022 | |
| Medtronic USA, INC. | $22.05 | 2020 | |
| Corium, LLC | $21.84 | 2023 | Adlarity |
| Avion Pharmaceuticals | $21.67 | 2022 | |
| Sandoz INC. | $20.61 | 2024 | |
| Zogenix INC. | $18.90 | 2021 | |
| Hospira, INC. | $18.15 | 2022 | |
| Tonix Medicines, INC. | $17.62 | 2025 | Zembrace Symtouch |
| Merz North America, INC. | $17.48 | 2019 | |
| Nevro Corp. | $16.87 | 2024 | Senza |
| Bausch Health US, LLC | $16.79 | 2019 | |
| Akcea Therapeutics, INC. | $16.51 | 2021 | |
| Promius Pharma LLC | $12.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.47 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$17,640.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.